Abstract:Hyperkalemia is a common metabolic problem in patients with chronic kidney disease. Although oral medications and hemodialysis are clinically applied for lowering serum potassium, the intrinsic limitations encourage alternative therapy in the trend of adsorbent-based miniaturized blood purification devices. Cells serve as the biological K+ storage units that accumulate K+ through multiple mechanisms. Inspired by cells, our strategy aims at favorable permeation and enrichment of K+ in the microsphere. We incorporate cation-affinitive groups into core-shell structures with submicron-sized phase separation. These nano-spaced side-groups cooperate to form interlinked clusters, where crown ethers with Angstrom-scale ring for size-matched complexation, while ionic sulfonic acid groups for hydrophilicity and charge-buffering. The unique structure with such non-covalent interactions facilitates K+ for permeation across the shell and binding to the core while also ensuring mechanical strength and anti-swelling durability in biofluids. The microspheres exhibit high selectivity ratios of K+ (SK/Na, SK/Ca, SK/Mg up to 9.8, 21.6, and 17.7). As column adsorbents for hemoperfusion simulation, they effectively lower elevated K+ levels to the normal range (clearance rates up to 44.4%/45.3% for hyperkalemic human serum/blood). Blood compatibility tests show low protein adsorption, preferable hemocyte compatibility, and anticoagulation property in vitro. This promising strategy has clinical potential for hyperkalemia in high-risk patients. STATEMENT OF SIGNIFICANCE: Hyperkalemia (serum potassium >5 mmol/L) is a common complication in chronic renal failure patients. The limitations of existing treatments prompt a shift to wearable artificial kidney technology for clinical convenience and efficacy. Existing treatments have limitations, and we turn to adsorbent-based miniaturized blood purification devices in the prospect of wearable artificial kidney technology. There exists a lack of ion-specific adsorbents applied in extracorporeal circuits to redress electrolyte imbalances like hyperkalemia. Inspired by cells, we aim at the favorable permeation and enrichment of K+ by microspheres. The microspheres have a microphase-isolated core-shell structure, whose nano-spaced groups form cation-affinitive clusters. Selective K+ removal and blood compatibility are achieved. We expect this strategy to enlighten alternative hyperkalemia therapy for these high-risk patients.

Adsorption of suppressor cell activity on mouse macrophage monolayers.

Upscaling of a living membrane for bioartificial kidney device

Ex Vivo Anchored PD‐L1 Functionally Prevent in Vivo Renal Allograft Rejection

A bioartificial environment for kidney epithelial cells based on a supramolecular polymer basement membrane mimic and an organotypical culture system

Using an Adaptation of a Binary Search Tree to Improve the NSGA-II Nondominated Sorting Procedure

The bioartificial kidney and bioengineered membranes in acute kidney injury.

Improvement of Cytokine Response and Survival Time by Bioartificial Kidney Therapy in Acute Uremic Pigs with Multi-Organ Dysfunction.

A haemocompatible and scalable nanoporous adsorbent monolith synthesised using a novel lignin binder route to augment the adsorption of poorly removed uraemic toxins in haemodialysis

Construction of Bioartificial Renal Tubule Assist Device in Vitro and Its Function of Transporting Sodium and Glucose

Extracorporeal Endotoxin Removal by Novel L-Serine Grafted PVDF Membrane Modules

New Dialysis Technology and Biocompatible Materials

Removal of Protein-Bound Uremic Toxins by Liposome-Supported Peritoneal Dialysis

An immunocompetent human kidney on-a-chip model to study renal inflammation and immune-mediated injury

Recent trends in therapeutic application of engineered blood purification materials for kidney disease

B11 Complications, Cardiovascular Morbidity and Mortality (T357 - T389)

In Vivo Kidney Allograft Endothelial Specific Scavengers for On‐Site Inflammation Reduction under Antibody‐Mediated Rejection

Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver System

Artificial Kidney Engineering: The Development of Dialysis Membranes for Blood Purification

Bioartificial Kidney Alters Cytokine Response and Survival Time in Acute Uremic Pigs with Multiple Organ Dysfunction Syndrome

Mixed matrix membranes with incorporated glycosaminoglycans have good blood biocompatibility combined to high toxin removal

Cell-inspired selective potassium removal towards hyperkalemia therapy by microphase-isolated core-shell microspheres